華通醫藥(002758.SZ):董事長汪路平辭職
格隆匯 10 月 8日丨華通醫藥(002758.SZ)公告,近日收到董事長汪路平、董事金鼎、董事劉文琪、監事會主席張全、監事餘羣建提交的書面辭職報告。其中,汪路平因工作調整原因申請辭去公司董事長、戰略委員會召集人的職務,辭職後汪路平不再擔任公司任何職務;金鼎因工作調整原因申請辭去公司董事的職務,辭職後金鼎仍擔任公司董事會祕書職務;劉文琪因工作調整原因申請辭去公司董事、審計委員會委員職務,辭職後劉文琪在公司擔任的職務將另行安排;張全因工作調整原因申請辭去公司監事會主席職務,辭職後張全不再擔任公司任何職務;餘羣建因工作調整原因申請辭去公司監事的職務,辭職後餘羣建仍擔任公司審計部負責人職務。
為保障公司董事會及監事會正常運作,公司於2020年9月30日召開第四屆董事會第七次會議審議通過了《關於提名公司第四屆董事會非獨立董事候選人的議案》提名林上華、姚瑤、李文華為公司第四屆董事會非獨立董事候選人,任期自股東大會審議通過之日起至公司第四屆董事會任期屆滿之日止。公司於2020年9月30日召開第四屆監事會第六次會議審議通過了《關於提名第四屆監事會非職工監事候選人的議案》提名陳志浩、王炳武為公司第四屆監事會非職工監事候選人,任期自股東大會審議通過之日起至公司第四屆監事會任期屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.